Skip to main content

Advertisement

Log in

Application of conditionally replicating adenoviruses in tumor early diagnosis technology, gene-radiation therapy and chemotherapy

  • Mini-Review
  • Published:
Applied Microbiology and Biotechnology Aims and scope Submit manuscript

Abstract

Conditionally replicating adenoviruses (CRAds), or known as replication-selective adenoviruses, were discovered as oncolytic gene vectors several years ago. They have a strong ability of scavenging tumor and lesser toxicity to normal tissue. CRAds not only have a tumor-killing ability but also can combine with gene therapy, radiotherapy, and chemotherapy to induce tumor cell apoptosis. In this paper, we review the structure of CRAds and CRAd vectors and summarize the current application of CRAds in tumor detection as well as in radiotherapy and suicide gene-mediating chemotherapy. We also propose further research strategies that can improve the application value of CRAds, including enhancing tumor destruction effect, further reducing toxic effect, reducing immunogenicity, constructing CRAds that can target tumor stem cells, and trying to use mesenchymal stem cells (MSCs) as the carriers for oncolytic adenoviruses. As their importance to cancer diagnosis, gene-radiation, and chemotherapy, CRAds may play a considerable role in clinical diagnosis and various cancer treatments in the future.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  • Akbulut H, Zhang L, Tang Y, Deisseroth A (2003) Cytotoxic effect of replication-competent adenoviral vectors carrying L-plastin promoter regulated E1A and cytosine deaminase genes in cancers of the breast, ovary and colon. Cancer Gene Ther 10:388–395

    Article  CAS  PubMed  Google Scholar 

  • Alva A, Friedlander T, Clark M, Huebner T, Daignault S, Hussain M, Lee C, Hafez K, Hollenbeck B, Weizer A, Premasekharan G, Tran T, Fu C, Ionescu-Zanetti C, Schwartz M, Fan A, Paris P (2015) Circulating tumor cells as potential biomarkers in bladder cancer. J Urol 194:790–798

    Article  CAS  PubMed  Google Scholar 

  • Anton M, Gomaa IE, von Lukowicz T, Molls M, Gansbacher B, Wurschmidt F (2005) Optimization of radiation controlled gene expression by adenoviral vectors in vitro. Cancer Gene Ther 12:640–646

    Article  CAS  PubMed  Google Scholar 

  • Banys-Paluchowski M, Schneck H, Blassl C, Schultz S, Meier-Stiegen F, Niederacher D, Krawczyk N, Ruckhaeberle E, Fehm T, Neubauer H (2015) Prognostic relevance of circulating tumor cells in molecular subtypes of breast cancer. Geburtshilfe Frauenheilkd 75:232–237

    Article  PubMed  PubMed Central  Google Scholar 

  • Berkner KL (1988) Development of adenovirus vectors for the expression of heterologous genes. Biotechniques 6:616–629

    CAS  PubMed  Google Scholar 

  • Boone DN, Qi Y, Li Z, Hann SR (2011) Egr1 mediates p53-independent c-Myc-induced apoptosis via a noncanonical ARF-dependent transcriptional mechanism. Proc Natl Acad Sci U S A 108:632–637

    Article  CAS  PubMed  Google Scholar 

  • Borgen E, Naume B, Nesland JM, Nowels KW, Pavlak N, Ravkin I, Goldbard S (2001) Use of automated microscopy for the detection of disseminated tumor cells in bone marrow samples. Cytometry 46:215–221

    Article  CAS  PubMed  Google Scholar 

  • Breyer B, Jiang W, Cheng H, Zhou L, Paul R, Feng T, He TC (2001) Adenoviral vector-mediated gene transfer for human gene therapy. Current gene therapy 1:149–162

    Article  CAS  PubMed  Google Scholar 

  • Brinkmann K, Hombach A, Seeger JM, Wagner-Stippich D, Klubertz D, Kronke M, Abken H, Kashkar H (2014) Second mitochondria-derived activator of caspase (SMAC) mimetic potentiates tumor susceptibility toward natural killer cell-mediated killing. Leukemia & lymphoma 55:645–651

    Article  CAS  Google Scholar 

  • Cody JJ, Douglas JT (2009) Armed replicating adenoviruses for cancer virotherapy. Cancer Gene Ther 16:473–488

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Conrad C, Miller CR, Ji Y, Gomez-Manzano C, Bharara S, McMurray JS, Lang FF, Wong F, Sawaya R, Yung WK, Fueyo J (2005) Delta24-hyCD adenovirus suppresses glioma growth in vivo by combining oncolysis and chemosensitization. Cancer Gene Ther 12:284–294

    Article  CAS  PubMed  Google Scholar 

  • Cristofanilli M, Hayes DF, Budd GT, Ellis MJ, Stopeck A, Reuben JM, Doyle GV, Matera J, Allard WJ, Miller MC, Fritsche HA, Hortobagyi GN, Terstappen LW (2005) Circulating tumor cells: a novel prognostic factor for newly diagnosed metastatic breast cancer. J Clin Oncol Off J Am Soc Clin Oncol 23:1420–1430

    Article  Google Scholar 

  • Cristofanilli M, Mendelsohn J (2006) Circulating tumor cells in breast cancer: advanced tools for “tailored” therapy? Proc Natl Acad Sci U S A 103:17073–17074

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Crystal RG (2014) Adenovirus: the first effective in vivo gene delivery vector. Hum Gene Ther 25:3–11

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Das SK, Sarkar S, Dash R, Dent P, Wang XY, Sarkar D, Fisher PB (2012) Chapter one—Cancer Terminator viruses and approaches for enhancing therapeutic outcomes. Adv Cancer Res 115:1–38

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Dembinski JL, Spaeth EL, Fueyo J, Gomez-Manzano C, Studeny M, Andreeff M, Marini FC (2010) Reduction of nontarget infection and systemic toxicity by targeted delivery of conditionally replicating viruses transported in mesenchymal stem cells. Cancer Gene Ther 17:289–297

    Article  CAS  PubMed  Google Scholar 

  • Douglas JT (2007) Adenoviral vectors for gene therapy. Mol Biotechnol 36:71–80

    Article  CAS  PubMed  Google Scholar 

  • Fallaux FJ, Bout A, van der Velde I, van den Wollenberg DJ, Hehir KM, Keegan J, Auger C, Cramer SJ, van Ormondt H, van der Eb AJ, Valerio D, Hoeben RC (1998) New helper cells and matched early region 1-deleted adenovirus vectors prevent generation of replication-competent adenoviruses. Hum Gene Ther 9:1909–1917

    Article  CAS  PubMed  Google Scholar 

  • Feng J, Wang X, Liao Y, Feng J, Tang L (2016) A novel conditional gene silencing method using a tumor-specific and heat-inducible siRNA system. Journal of industrial microbiology & biotechnology 43:761–770

    Article  CAS  Google Scholar 

  • Fiegl M, Kircher B, Zojer N (2003) Correspondence re: T. Fehm et al., Cytogenetic evidence that circulating epithelial cells in patients with carcinoma are malignant. Clin. Cancer Res, 8: 2073–2084, 2002 Clinical cancer research: an official journal of the American Association for Cancer Research 9:1224–1225; author reply 1226

  • Gertler R, Rosenberg R, Fuehrer K, Dahm M, Nekarda H, Siewert JR (2003) Detection of circulating tumor cells in blood using an optimized density gradient centrifugation. Recent Results Cancer Res 162:149–155

    Article  PubMed  Google Scholar 

  • Ghossein RA, Bhattacharya S, Rosai J (1999) Molecular detection of micrometastases and circulating tumor cells in solid tumors. Clinical cancer research : an official journal of the American Association for Cancer Research 5:1950–1960

    CAS  Google Scholar 

  • Glinskii AB, Smith BA, Jiang P, Li XM, Yang M, Hoffman RM, Glinsky GV (2003) Viable circulating metastatic cells produced in orthotopic but not ectopic prostate cancer models. Cancer Res 63:4239–4243

    CAS  PubMed  Google Scholar 

  • Gotoh A, Nagaya H, Kanno T, Tagawa M, Nishizaki T (2013) Fiber-substituted conditionally replicating adenovirus Ad5F35 induces oncolysis of human bladder cancer cells in in vitro analysis. Urology 81(920):e927–e911

    Google Scholar 

  • Grunwald GK, Klutz K, Willhauck MJ, Schwenk N, Senekowitsch-Schmidtke R, Schwaiger M, Zach C, Goke B, Holm PS, Spitzweg C (2013) Sodium iodide symporter (NIS)-mediated radiovirotherapy of hepatocellular cancer using a conditionally replicating adenovirus. Gene Ther 20:625–633

    Article  CAS  PubMed  Google Scholar 

  • Hao HC, Yao DJ (2015) Detection of cancer cells on a chip. Curr Top Med Chem 15:1543–1550

    Article  CAS  PubMed  Google Scholar 

  • Harada H (2011) How can we overcome tumor hypoxia in radiation therapy? J Radiat Res 52:545–556

    Article  CAS  PubMed  Google Scholar 

  • Hemminki O, Bauerschmitz G, Hemmi S, Lavilla-Alonso S, Diaconu I, Guse K, Koski A, Desmond RA, Lappalainen M, Kanerva A, Cerullo V, Pesonen S, Hemminki A (2011) Oncolytic adenovirus based on serotype 3. Cancer Gene Ther 18:288–296

    Article  CAS  PubMed  Google Scholar 

  • Hu Y, Ouyang W, Wu F, Cao CH, Wang K, Liao ZK, Zhong YH, Zhou FX, Liu SQ, Xia L, Zhou YF, Xie CH (2009) Enhanced radiosensitivity of SW480 cells via TRAIL up-regulation mediated by Egr-1 promoter. Oncol Rep 22:765–771

    CAS  PubMed  Google Scholar 

  • Jounaidi Y, Doloff JC, Waxman DJ (2007) Conditionally replicating adenoviruses for cancer treatment. Curr Cancer Drug Targets 7:285–301

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kanerva A, Zinn KR, Chaudhuri TR, Lam JT, Suzuki K, Uil TG, Hakkarainen T, Bauerschmitz GJ, Wang M, Liu B, Cao Z, Alvarez RD, Curiel DT, Hemminki A (2003) Enhanced therapeutic efficacy for ovarian cancer with a serotype 3 receptor-targeted oncolytic adenovirus. Molecular therapy: the journal of the American Society of Gene Therapy 8:449–458

    Article  CAS  Google Scholar 

  • Kasimir-Bauer S (2012) Circulating tumor cells as markers for cancer risk assessment and treatment monitoring. Mol Diag Ther 13:209–215

    Article  Google Scholar 

  • Khaider NG, Lane D, Matte I, Rancourt C, Piche A (2012) Targeted ovarian cancer treatment: the TRAILs of resistance. Am J Cancer Res 2:75–92

    CAS  PubMed  Google Scholar 

  • Kim JS, Lee SD, Lee SJ, Chung MK (2013) Development of an immunotherapeutic adenovirus targeting hormone-independent prostate cancer. Onco Targets and therapy 6:1635–1642

    Article  CAS  Google Scholar 

  • Kirn D, Martuza RL, Zwiebel J (2001) Replication-selective virotherapy for cancer: biological principles, risk management and future directions. Nat Med 7:781–787

    Article  CAS  PubMed  Google Scholar 

  • Kojima Y, Honda K, Hamada H, Kobayashi N (2009) Oncolytic gene therapy combined with double suicide genes for human bile duct cancer in nude mouse models. J Surg Res 157:e63–e70

    Article  CAS  PubMed  Google Scholar 

  • Kovesdi I, Brough DE, Bruder JT, Wickham TJ (1997) Adenoviral vectors for gene transfer. Curr Opin Biotechnol 8:583–589

    Article  CAS  PubMed  Google Scholar 

  • Kranzler J, Tyler MA, Sonabend AM, Ulasov IV, Lesniak MS (2009) Stem cells as delivery vehicles for oncolytic adenoviral virotherapy. Current gene therapy 9:389–395

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Krivacic RT, Ladanyi A, Curry DN, Hsieh HB, Kuhn P, Bergsrud DE, Kepros JF, Barbera T, Ho MY, Chen LB, Lerner RA, Bruce RH (2004) A rare-cell detector for cancer. Proc Natl Acad Sci U S A 101:10501–10504

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Lahoz A, Vila MR, Fabre M, Miquel JM, Rivas M, Maines J, Castell JV, Gomez-Lechon MJ (2013) An in vitro tool to assess cytochrome P450 drug biotransformation-dependent cytotoxicity in engineered HepG2 cells generated by using adenoviral vectors Toxicology in vitro: an international journal published in association with BIBRA 27:1410–1415

  • Li S, Qi Z, Li H, Hu J, Wang D, Wang X, Feng Z (2015) Conditionally replicating oncolytic adenoviral vector expressing arresten and tumor necrosis factor-related apoptosis-inducing ligand experimentally suppresses lung carcinoma progression. Mol Med Rep 12:2068–2074

    CAS  PubMed  Google Scholar 

  • Li X, Mao Q, Wang D, Xia H (2012) A novel Ad5/11 chimeric oncolytic adenovirus for improved glioma therapy. Int J Oncol 41:2159–2165

    CAS  PubMed  Google Scholar 

  • Liao Y, Feng J, Yi Q, Cui H, He L, Tang L (2013) A siRNA system based on HSP70 promoter results in controllable and powerful gene silencing by heat-induction. Biotechnol Prog 29:1289–1297

    Article  CAS  PubMed  Google Scholar 

  • Liao Y, Tang L (2014) The critical roles of HSC70 in physiological and pathological processes. Curr Pharm Des 20:101–107

    Article  CAS  PubMed  Google Scholar 

  • Liao Y, Tang L (2016) Inducible RNAi system and its application in novel therapeutics. Crit Rev Biotechnol 36:630–638

    CAS  PubMed  Google Scholar 

  • Liu T, Ye L, He Y, Chen X, Peng J, Zhang X, Yi H, Peng F, Leng A (2011) Combination gene therapy using VEGF-shRNA and fusion suicide gene yCDglyTK inhibits gastric carcinoma growth. Exp Mol Pathol 91:745–752

    Article  CAS  PubMed  Google Scholar 

  • Lou F, Chen X, Jalink M, Zhu Q, Ge N, Zhao S, Fang X, Fan Y, Bjorkholm M, Liu Z, Xu D (2007) The opposing effect of hypoxia-inducible factor-2alpha on expression of telomerase reverse transcriptase. Molecular cancer research : MCR 5:793–800

    Article  CAS  PubMed  Google Scholar 

  • Martinez-Quintanilla J, He D, Wakimoto H, Alemany R, Shah K (2015) Encapsulated stem cells loaded with hyaluronidase-expressing oncolytic virus for brain tumor therapy. Molecular therapy : the journal of the American Society of Gene Therapy 23:108–118

    CAS  Google Scholar 

  • Metildi CA, Hoffman RM, Bouvet M (2013) Fluorescence-guided surgery and fluorescence laparoscopy for gastrointestinal cancers in clinically-relevant mouse models. Gastroenterol Res Pract 2013:290634

    Article  PubMed  PubMed Central  Google Scholar 

  • Morimoto E, Inase N, Mlyake S, Yoshizawa Y (2001) Adenovirus-mediated suicide gene transfer to small cell lung carcinoma using a tumor-specific promoter. Anticancer Res 21:329–331

    CAS  PubMed  Google Scholar 

  • Moussavi-Harami SF, Wisinski KB, Beebe DJ (2014) Circulating tumor cells in metastatic breast cancer: a prognostic and predictive marker. Journal of patient-centered research and reviews 1:85–92

    Article  PubMed  PubMed Central  Google Scholar 

  • Nielsen OS, Horsman M, Overgaard J (2001) A future for hyperthermia in cancer treatment? Eur J Cancer 37:1587–1589

    Article  CAS  PubMed  Google Scholar 

  • O’Brien T (2000) Adenoviral vectors and gene transfer to the blood vessel wall. Arterioscler Thromb Vasc Biol 20:1414–1416

    Article  PubMed  Google Scholar 

  • Pailler E, Auger N, Lindsay CR, Vielh P, Islas-Morris-Hernandez A, Borget I, Ngo-Camus M, Planchard D, Soria JC, Besse B, Farace F (2015) High level of chromosomal instability in circulating tumor cells of ROS1-rearranged non-small-cell lung cancer. Annals of oncology: official journal of the European Society for Medical Oncology / ESMO 26:1408–1415

    CAS  Google Scholar 

  • Pantel K, Alix-Panabieres C, Riethdorf S (2009) Cancer micrometastases. Nature reviews Clinical oncology 6:339–351

    Article  CAS  PubMed  Google Scholar 

  • Pierrefite-Carle V, Baque P, Gavelli A, Brossette N, Benchimol D, Bourgeon A, Saint Paul MC, Staccini P, Rossi B (2002) Subcutaneous or intrahepatic injection of suicide gene modified tumour cells induces a systemic antitumour response in a metastatic model of colon carcinoma in rats. Gut 50:387–391

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Portsmouth D, Hlavaty J, Renner M (2007) Suicide genes for cancer therapy. Mol Asp Med 28:4–41

    Article  CAS  Google Scholar 

  • Qu W, Zhu Z, Zhao L, He A, Zheng X (2012) Conditionally replicating adenovirus SG500-expressed mutant Dm-dNK gene for breast cancer therapy. Int J Oncol 41:2175–2183

    CAS  PubMed  Google Scholar 

  • Racila E, Euhus D, Weiss AJ, Rao C, McConnell J, Terstappen LW, Uhr JW (1998) Detection and characterization of carcinoma cells in the blood. Proc Natl Acad Sci U S A 95:4589–4594

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Rivera AA, Davydova J, Schierer S, Wang M, Krasnykh V, Yamamoto M, Curiel DT, Nettelbeck DM (2004) Combining high selectivity of replication with fiber chimerism for effective adenoviral oncolysis of CAR-negative melanoma cells. Gene Ther 11:1694–1702

    Article  CAS  PubMed  Google Scholar 

  • Rodriguez R, Schuur ER, Lim HY, Henderson GA, Simons JW, Henderson DR (1997) Prostate attenuated replication competent adenovirus (ARCA) CN706: a selective cytotoxic for prostate-specific antigen-positive prostate cancer cells. Cancer Res 57:2559–2563

    CAS  PubMed  Google Scholar 

  • Russell WC (2009) Adenoviruses: update on structure and function. The Journal of general virology 90:1–20

    Article  CAS  PubMed  Google Scholar 

  • Sakurai F, Fujiwara T, Mizuguchi H (2013) Development of a detection system for circulating tumor cells in peripheral blood using a next generation conditionally-replicating adenovirus. Yakugaku zasshi: Journal of the Pharmaceutical Society of Japan 133:291–296

    Article  CAS  PubMed  Google Scholar 

  • Seregin SS, Hartman ZC, Appledorn DM, Godbehere S, Jiang H, Frank MM, Amalfitano A (2010) Novel adenovirus vectors ‘capsid-displaying’ a human complement inhibitor. Journal of innate immunity 2:353–359

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Sharon D, Schumann M, MacLeod S, McPherson R, Chaurasiya S, Shaw A, Hitt MM (2013) 2-aminopurine enhances the oncolytic activity of an E1b-deleted adenovirus in hepatocellular carcinoma cells. PLoS One 8:e65222

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Shen Y, Shenk TE (1995) Viruses and apoptosis. Curr Opin Genet Dev 5(1):105–111

  • Shim SH, Lee CT, Hun Hah J, Lee JJ, Park SW, Heo DS, Sung MW (2010) Conditionally replicating adenovirus improves gene replication efficiency and anticancer effect of E1-deleted adenovirus carrying TRAIL in head and neck squamous cell carcinoma. Cancer Sci 101:482–487

    Article  CAS  PubMed  Google Scholar 

  • Shioyama Y, Tsuji H, Suefuji H, Sinoto M, Matsunobu A, Toyama S, Nakamura K, Kudo S (2015) Particle radiotherapy for prostate cancer. International journal of urology: official journal of the Japanese Urological Association 22:33–39

    Article  Google Scholar 

  • Smith RA, Cokkinides V, Brooks D, Saslow D, Brawley OW (2010) Cancer screening in the United States, 2010: a review of current American Cancer Society guidelines and issues in cancer screening. CA Cancer J Clin 60:99–119

    Article  PubMed  Google Scholar 

  • Thaci B, Ahmed AU, Ulasov IV, Tobias AL, Han Y, Aboody KS, Lesniak MS (2012) Pharmacokinetic study of neural stem cell-based cell carrier for oncolytic virotherapy: targeted delivery of the therapeutic payload in an orthotopic brain tumor model. Cancer Gene Ther 19:431–442

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Tian J, Xu Z, Smith JS, Hofherr SE, Barry MA, Byrnes AP (2009) Adenovirus activates complement by distinctly different mechanisms in vitro and in vivo: indirect complement activation by virions in vivo. J Virol 83:5648–5658

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Verdaguer N, Ferrero D, Murthy MR (2014) Viruses and viral proteins. IUCrJ 1:492–504

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Vona G, Sabile A, Louha M, Sitruk V, Romana S, Schutze K, Capron F, Franco D, Pazzagli M, Vekemans M, Lacour B, Brechot C, Paterlini-Brechot P (2000) Isolation by size of epithelial tumor cells : a new method for the immunomorphological and molecular characterization of circulatingtumor cells. Am J Pathol 156:57–63

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Wendel M, Bazhenova L, Boshuizen R, Kolatkar A, Honnatti M, Cho EH, Marrinucci D, Sandhu A, Perricone A, Thistlethwaite P, Bethel K, Nieva J, Heuvel M, Kuhn P (2012) Fluid biopsy for circulating tumor cell identification in patients with early-and late-stage non-small cell lung cancer: a glimpse into lung cancer biology. Phys Biol 9:016005

    Article  PubMed  PubMed Central  Google Scholar 

  • Witzig TE, Bossy B, Kimlinger T, Roche PC, Ingle JN, Grant C, Donohue J, Suman VJ, Harrington D, Torre-Bueno J, Bauer KD (2002) Detection of circulating cytokeratin-positive cells in the blood of breast cancer patients using immunomagnetic enrichment and digital microscopy. Clinical cancer research: an official journal of the American Association for Cancer Research 8:1085–1091

    Google Scholar 

  • Wu JH, Wang HF, Wang ZC, Xu K, Qi YL, Li JH, Gong SL, Liu Y, Liu Y (2013) Conditionally replicating adenovirus combined with gene-targeted radiotherapy induces apoptosis via TRAIL death receptors in MDA-MB-231 cells. Mol Med Rep 8:299–305

    CAS  PubMed  Google Scholar 

  • Wu P, Sokoll LJ, Kudrolli TA, Chowdhury WH, Ma R, Liu MM, Rodriguez R, Lupold SE (2014) A novel approach for detecting viable and tissue-specific circulating tumor cells through an adenovirus-based reporter vector. Prostate 74:1286–1296

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Xia X, Ji T, Chen P, Li X, Fang Y, Gao Q, Liao S, You L, Xu H, Ma Q, Wu P, Hu W, Wu M, Cao L, Li K, Weng Y, Han Z, Wei J, Liu R, Wang S, Xu G, Wang D, Zhou J, Ma D (2011) Mesenchymal stem cells as carriers and amplifiers in CRAd delivery to tumors. Mol Cancer 10:134

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Yoshimura M, Itasaka S, Harada H, Hiraoka M (2013) Microenvironment and radiation therapy. BioMed research international 2013:685308

    Article  PubMed  Google Scholar 

  • Yu DC, Chen Y, Dilley J, Li Y, Embry M, Zhang H, Nguyen N, Amin P, Oh J, Henderson DR (2001) Antitumor synergy of CV787, a prostate cancer-specific adenovirus, and paclitaxel and docetaxel. Cancer Res 61:517–525

    CAS  PubMed  Google Scholar 

  • Zhang Y, Hao Y, Sun Q, Peng C (2015) Role of Smac in apoptosis of lung cancer cells A549 induced by Taxol. Clinical laboratory 61:17–21

    CAS  PubMed  Google Scholar 

  • Zheng FQ, Xu Y, Yang RJ, Wu B, Tan XH, Qin YD, Zhang QW (2009) Combination effect of oncolytic adenovirus therapy and herpes simplex virus thymidine kinase/ganciclovir in hepatic carcinoma animal models. Acta Pharmacol Sin 30:617–627

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgments

This study was supported by grants from the Natural Science foundation of China (NO.31670952) and also thanks the support from the Chongqing Engineering Laboratory in Vascular Implants, the National “111 Plan” Base (B06023) and the Public Experiment Center of State Bio-industrial Base (Chongqing), China.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Liling Tang.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical statement

The authors confirm that the article does not contain any studies with human participants performed by any of the authors.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Li, S., Ou, M., Wang, G. et al. Application of conditionally replicating adenoviruses in tumor early diagnosis technology, gene-radiation therapy and chemotherapy. Appl Microbiol Biotechnol 100, 8325–8335 (2016). https://doi.org/10.1007/s00253-016-7806-z

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00253-016-7806-z

Keywords

Navigation